Results 71 to 80 of about 805,395 (207)

Viral and cellular translation during SARS‐CoV‐2 infection

open access: yesFEBS Open Bio, 2022
SARS‐CoV‐2 is a betacoronavirus that emerged in China in December 2019 and which is the causative agent of the Covid‐19 pandemic. This enveloped virus contains a large positive‐sense single‐stranded RNA genome.
Gilbert Eriani, Franck Martin
doaj   +1 more source

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

open access: yesScience, 2021
Unmitigated spread in Brazil Despite an extensive network of primary care availability, Brazil has suffered profoundly during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Using daily data from state health offices, Castro et
N. Faria   +71 more
semanticscholar   +1 more source

SARS-CoV-2 Infection in Children

open access: yesNew England Journal of Medicine, 2020
SARS-CoV-2 Infection in Children In this report, investigators in Wuhan, China, describe the spectrum of Covid-19 illness in children under the age of 16 years.
Xiaoxia Lu   +24 more
semanticscholar   +1 more source

Acquired immunity against SARS‐CoV‐2 infection and vaccination

open access: yesEMBO Molecular Medicine, 2023
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has caused more than 700 million confirmed infections and ~7 million fatalities worldwide since its emergence in December 2019.
Laurent Renia, Lisa FP Ng
doaj   +1 more source

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

open access: yesScience, 2020
Undetected cases The virus causing coronavirus disease 2019 (COVID-19) has now become pandemic. How has it managed to spread from China to all around the world within 3 to 4 months? Li et al.
Ruiyun Li   +6 more
semanticscholar   +1 more source

Adult‐onset Still's disease after SARS‐Cov‐2 infection

open access: yesClinical Case Reports, 2023
Adult‐onset Still's disease (AOSD) is an uncommon inflammatory disorder. AOSD and SARS‐Cov‐2 infection share clinical and laboratory features, including systemic inflammation.
Tayssir Ben Achour   +8 more
doaj   +1 more source

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

open access: yesIntensive Care Medicine, 2020
A novel infectious disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in Wuhan, China, in December 2019. The disease (COVID-19) spread rapidly, reaching epidemic proportions in China, and has been found in 27 ...
Haibo Zhang   +4 more
semanticscholar   +1 more source

Infección por SARS-COV-2 en trabajadores de la salud: análisis de riesgo epidemiológico en una institución de alta complejidad de Bogotá, Colombia, 2020

open access: yesInfectio, 2022
Objective: To determine the incidence of SARS-CoV-2 infection and its association with sociodemographic, clinical, and occupational characteristics in health workers (HCWs) in the COVID-19 risk area.Material and method: Longitudinal analytical study in a
Milcíades Ibáñez-Pinilla
doaj   +1 more source

Cotton flower metabolites inhibit SARS‐CoV‐2 main protease

open access: yesFEBS Open Bio, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been spreading globally for over 2 years, causing serious contagious disease and incalculable damage.
Yufang Zhang   +9 more
doaj   +1 more source

Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2022
A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy